A simple blood test may flag hidden insulin problems in PCOS

NCT ID NCT07739953

Ongoing Diagnosis Sponsor: Guangdong Women and Children Hospital Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study looks at whether a protein called ApoC3 in the blood can help identify insulin resistance in women with polycystic ovary syndrome (PCOS), a common cause of infertility and other health issues. Researchers will measure ApoC3 levels in 200 women with PCOS and compare them with standard measures of insulin resistance. The goal is to see if ApoC3 could serve as a quick, reliable biomarker for early screening and better management of PCOS-related complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ApoC3 protein detection kit (blood test)
What this could lead to: If successful, this could lead to a simple blood test to identify insulin resistance in women with PCOS, enabling earlier intervention and better management of related health risks.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The biomarker's accuracy and usefulness in routine practice remain to be validated in larger, more diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PCOS (POLYCYSTIC OVARY SYNDROME)

Contacts and locations

Locations

Guangdong Women and Children Hospital

Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.